Genetic characterization of TET1, TET2, and TET3 alterations in myeloid malignancies
Omar Abdel‐Wahab(Memorial Sloan Kettering Cancer Center), Ross L. Levine(Memorial Sloan Kettering Cancer Center), Miloslav Beran(The University of Texas MD Anderson Cancer Center), Ann Mullally(VA Palo Alto Health Care System), Igor Dolgalev, Adriana Heguy, Jay Patel(University of Utah), Martha Wadleigh(Dana-Farber Cancer Institute), Guillermo Garcia‐Manero(The University of Texas MD Anderson Cancer Center), Outi Kilpivaara, Benjamin L. Ebert(Dana-Farber Cancer Institute), Richard M. Stone(Dana-Farber Cancer Institute), Michelle M. Le Beau(University of Chicago), Cyrus V. Hedvat(Memorial Sloan Kettering Cancer Center), Elisabeth Paietta(Montefiore Medical Center), John D. Crispino(St. Jude Children's Research Hospital), Kety Huberman, JinJuan Yao(Memorial Sloan Kettering Cancer Center), Sébastien Malinge(The Kids Research Institute Australia), Hagop M. Kantarjian(The University of Texas MD Anderson Cancer Center), Sabrena Thomas, Martin S. Tallman(Memorial Sloan Kettering Cancer Center), D. Gary Gilliland(Brigham and Women's Hospital), Rukhmi Bhat(Northwestern University)
Cited by 718
Related Papers
Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles
|Proceedings of the National Academy of Sciences|2005|56.5k
Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel
|Blood|2016|5.9k
The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes
|Blood|2009|4.4k
Systematic RNA interference reveals that oncogenic KRAS-driven cancers require TBK1
|Nature|2009|4.2k
The landscape of somatic copy-number alteration across human cancers
|Nature|2010|4.1k